105 related articles for article (PubMed ID: 8891291)
1. The effects of morphine on carrageenin-induced spinal c-Fos expression are completely blocked by beta-funaltrexamine, a selective mu-opioid receptor antagonist.
Honoré P; Buritova J; Besson JM
Brain Res; 1996 Sep; 732(1-2):242-6. PubMed ID: 8891291
[TBL] [Abstract][Full Text] [Related]
2. The effects of RB101, a mixed inhibitor of enkephalin-catabolizing enzymes, on carrageenin-induced spinal c-Fos expression are completely blocked by beta-funaltrexamine, a selective mu-opioid receptor antagonist.
Le Guen S; Honoré P; Catheline G; Fournié-Zaluski MC; Roques BP; Besson JM
Brain Res; 1999 Jul; 834(1-2):200-6. PubMed ID: 10407116
[TBL] [Abstract][Full Text] [Related]
3. Effects of opioid receptor antagonists on the effects of i.v. morphine on carrageenin evoked c-Fos expression in the superficial dorsal horn of the rat spinal cord.
Catheline G; Le Guen S; Besson JM
Brain Res; 1999 Apr; 824(1):105-11. PubMed ID: 10095048
[TBL] [Abstract][Full Text] [Related]
4. When is the maximal effect of pre-administered systemic morphine on carrageenin evoked spinal c-Fos expression in the rat?
Honoré P; Chapman V; Buritova J; Besson JM
Brain Res; 1995 Dec; 705(1-2):91-6. PubMed ID: 8821738
[TBL] [Abstract][Full Text] [Related]
5. Further evidence for the interaction of mu- and delta-opioid receptors in the antinociceptive effects of the dual inhibitor of enkephalin catabolism, RB101(S). A spinal c-Fos protein study in the rat under carrageenin inflammation.
Le Guen S; Catheline G; Fournié-Zaluski MC; Roques BP; Besson JM; Buritova J
Brain Res; 2003 Mar; 967(1-2):106-12. PubMed ID: 12650971
[TBL] [Abstract][Full Text] [Related]
6. Delta receptor involvement in morphine suppression of noxiously evoked activity of spinal WDR neurons in cats.
Omote K; Kitahata LM; Nakatani K; Collins JG
Brain Res; 1991 Jul; 554(1-2):299-303. PubMed ID: 1657291
[TBL] [Abstract][Full Text] [Related]
7. Infusion of beta-FNA into the thalamus attenuates morphine-induced c-Fos induction in the rat caudate putamen.
Frankel PS; Garcia MM; Harlan RE
Brain Res; 1999 Aug; 838(1-2):222-6. PubMed ID: 10446338
[TBL] [Abstract][Full Text] [Related]
8. To what extent do spinal interactions between an alpha-2 adrenoceptor agonist and a mu opioid agonist influence noxiously evoked c-Fos expression in the rat? A pharmacological study.
Honoré P; Chapman V; Buritova J; Besson JM
J Pharmacol Exp Ther; 1996 Jul; 278(1):393-403. PubMed ID: 8764375
[TBL] [Abstract][Full Text] [Related]
9. Spinal cord mechanisms of opioid tolerance and dependence: Fos-like immunoreactivity increases in subpopulations of spinal cord neurons during withdrawal [corrected].
Rohde DS; Detweiler DJ; Basbaum AI
Neuroscience; 1996 May; 72(1):233-42. PubMed ID: 8730720
[TBL] [Abstract][Full Text] [Related]
10. Morphine withdrawal precipitated by specific mu, delta or kappa opioid receptor antagonists: a c-Fos protein study in the rat central nervous system.
Le Guen S; Gestreau C; Besson JM
Eur J Neurosci; 2003 Jun; 17(11):2425-37. PubMed ID: 12814374
[TBL] [Abstract][Full Text] [Related]
11. Chronic treatment with systemic morphine induced tolerance to the systemic and peripheral antinociceptive effects of morphine on both carrageenin induced mechanical hyperalgesia and spinal c-Fos expression in awake rats.
Honoré P; Catheline G; Le Guen S; Besson JM
Pain; 1997 May; 71(1):99-108. PubMed ID: 9200179
[TBL] [Abstract][Full Text] [Related]
12. Intraplantar morphine depresses spinal c-Fos expression induced by carrageenin inflammation but not by noxious heat.
Honoré P; Buritova J; Besson JM
Br J Pharmacol; 1996 Jun; 118(3):671-80. PubMed ID: 8762093
[TBL] [Abstract][Full Text] [Related]
13. Concomitant administration of morphine and an N-methyl-D-aspartate receptor antagonist profoundly reduces inflammatory evoked spinal c-Fos expression.
Honoré P; Chapman V; Buritova J; Besson JM
Anesthesiology; 1996 Jul; 85(1):150-60. PubMed ID: 8694361
[TBL] [Abstract][Full Text] [Related]
14. Effects of endomorphin on substantia gelatinosa neurons in rat spinal cord slices.
Wu SY; Ohtubo Y; Brailoiu GC; Dun NJ
Br J Pharmacol; 2003 Nov; 140(6):1088-96. PubMed ID: 14530213
[TBL] [Abstract][Full Text] [Related]
15. Effects of U-69,593, a kappa-opioid receptor agonist, on carrageenin-induced peripheral oedema and Fos expression in the rat spinal cord.
Catheline G; Le Guen S; Besson JM
Eur J Pharmacol; 1999 Apr; 370(3):287-96. PubMed ID: 10334505
[TBL] [Abstract][Full Text] [Related]
16. Activation of c-fos expression in hypothalamic nuclei by mu- and kappa-receptor agonists: correlation with catecholaminergic activity in the hypothalamic paraventricular nucleus.
Laorden ML; Castells MT; Martínez MD; Martínez PJ; Milanés MV
Endocrinology; 2000 Apr; 141(4):1366-76. PubMed ID: 10746640
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of mu and kappa opioid antagonists on Fos-like immunoreactivity in extended amygdala.
Carr KD; Kutchukhidze N; Park TH
Brain Res; 1999 Mar; 822(1-2):34-42. PubMed ID: 10082881
[TBL] [Abstract][Full Text] [Related]
18. Cholecystokinin B receptor antagonism enhances the ability of a low dose of morphine to reduce c-Fos expression in the spinal cord of the rat.
Chapman V; Honoré P; Buritova J; Besson JM
Neuroscience; 1995 Aug; 67(3):731-9. PubMed ID: 7675199
[TBL] [Abstract][Full Text] [Related]
19. Role of the dorsal raphe nucleus in morphine-induced immediate early gene expression in the rat striatum.
Frankel PS; Harlan RE; Garcia MM
Brain Res; 1999 Sep; 842(1):220-3. PubMed ID: 10526114
[TBL] [Abstract][Full Text] [Related]
20. Effects of mu and kappa opioid receptor antagonists on glucoprivic induction of Fos immunoreactivity in the rat preoptic area and hypothalamus.
Briski KP; Teodecki L
Brain Res Bull; 1999 Jun; 49(3):181-7. PubMed ID: 10435781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]